Applied DNA Sciences, Inc. (APDN)
Chart Events
Performance Outlook
| Previous Close | 1.4000 |
| Open | 1.3201 |
| Bid | 1.3000 x 3000 |
| Ask | 1.3300 x 800 |
| Day's Range | 1.3201 - 1.4000 |
| 52 Week Range | 1.0800 - 8.1000 |
| Volume | |
| Avg. Volume | 67,830 |
| Market Cap | 10.952M |
| Beta (5Y Monthly) | 0.99 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.9130 |
| Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.33 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for APDN
Related Research
- Applied DNA Sciences, Inc.Daily – Vickers Top Buyers & Sellers for 03/28/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat2 months agoArgus Research
- Zacks
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
STONY BROOK, N.Y., May 12, 2022--Revenues at Record $6.2 Million, up 130% Year-over-Year; Cash at $6.5 Million Inclusive of Net Proceeds from Offering and Strong Cash Collections.
- RICKY SITOMER, CEO of Star Jets International, Inc. (OTCPink: JETR), Announces All-time Record First Quarter 2022 Revenue of $5,500,000, a Year over Year Increase in Revenue of 51%GlobeNewswire
- LiveWire Ergogenics Reports Financial Performance for the First Quarter of 2022 Revenue Increased by 392% and Net Profit by 103% Outlook for Second Half of 2022GlobeNewswire
- Business Wire
Applied DNA Schedules Fiscal 2022 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 12, 2022
STONY BROOK, N.Y., May 09, 2022--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in cell-free, enzymatic DNA production, today announced that it will report fiscal 2022 second quarter financial results after market close on Thursday, May 12, 2022. The Company’s management will discuss the results during a conference call and simultaneous webcast at 4:30 p.m. ET that same day. Presentation slides will also be posted to the ‘Company Events’ sub-page of the Comp
